Octride 0.05 MG Injection 1 ML is primarily used to manage acromegaly, a rare hormonal disorder characterised by excessive growth hormone production. It belongs to the class of medications known as synthetic somatostatin analogues.
In addition to its main use, this medicine helps manage symptoms associated with hormone-secreting tumours of the gastrointestinal tract, including carcinoid tumours. It also addresses neuroendocrine tumours in various parts of the digestive system and pituitary adenomas that produce excess thyroid-stimulating hormone. In emergency situations, it may be used to control bleeding from oesophageal varices.
The injection must be administered exclusively by trained healthcare professionals in clinical settings. You should inform your doctor about any pre-existing conditions like diabetes, gallbladder disease, thyroid disorders, or cardiac conditions before beginning treatment. If you notice any side effects while receiving this medicine, notify your doctor immediately. Continue with the prescribed treatment schedule for optimal results.